Cargando…

Influence of T2 Candida Testing for Rapid Diagnosis of Candida Infections on Antifungal Stewardship Efforts at a Large Academic Medical Center: A Retrospective, Single-center Study

BACKGROUND: Antimicrobial stewardship has traditionally focused on the optimal use of antibacterial agents. Much less attention is focused on the optimal use of antifungal therapy (AFT). The high mortality and emergence of resistance in invasive infections due to Candida presents a critical opportun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayes, Justin F, Turner, Orlando D, McCarty, Todd P, Manning, Malia, Hoesley, Craig J, Pappas, Peter G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631288/ http://dx.doi.org/10.1093/ofid/ofx163.1667

Ejemplares similares

Relationship of T2 Candida Panel to Disease Severity, Mortality and Time to Therapy in Patients with Candidemia
por: Turner, Orlando D, et al.
Publicado: (2017)

248. Thirty-Day Mortality Among Patients with Candidemia Diagnosed by T2Candida Assay Alone: Influence of Risk Factors and Candida Species
por: White, Cameron, et al.
Publicado: (2019)

1173. Ocular Candidiasis in Patients with Candidemia Diagnosed by Blood Culture Versus T2Candida® Assay
por: White, Cameron, et al.
Publicado: (2020)

Evaluation of an Antifungal Stewardship Initiative Targeting Micafungin at an Academic Medical Center
por: Keck, J. Myles, et al.
Publicado: (2023)

Antifungal Pipeline
por: McCarty, Todd Patrick, et al.
Publicado: (2021)

247. Evaluation of the T2Candida Panel as an Antifungal Stewardship Tool in Transplant and Non-Transplant Patients at a Tertiary Care Center
por: Sarfraz. Chaudhry, Zohra, et al.
Publicado: (2019)

258. False Negative Rate of T2Candida Assay in Blood Culture Positive Candidemia
por: McCarty, Todd, et al.
Publicado: (2019)

Identification and Antifungal Susceptibility Profiles of Candida nivariensis and Candida bracarensis in a Multi-Center Chinese Collection of Yeasts
por: Hou, Xin, et al.
Publicado: (2017)

Intensive Care Antifungal Stewardship Programme Based on T2Candida PCR and Candida Mannan Antigen: A Prospective Study
por: Helweg-Larsen, Jannik, et al.
Publicado: (2021)

Candida parapsilosis Candidemia Resistance Patterns and Treatment Outcomes: An Opportunity for Antifungal Stewardship
por: Fong, Gary, et al.
Publicado: (2017)

2450. Clinical Outcomes of Candida auris Infections at an Academic Medical Center
por: Wang, Yifan, et al.
Publicado: (2023)

Impact of antifungal stewardship interventions on the susceptibility of colonized Candida species in pediatric patients with malignancy
por: Amanati, Ali, et al.
Publicado: (2021)

188 Evaluation of Baseline QTc Interval and Azithromycin Prescribing in an Academic Medical Center
por: Lee, Rachael, et al.
Publicado: (2014)

Candida Empyema Thoracis at Two Academic Medical Centers: New Insights Into Treatment and Outcomes
por: Senger, Suheyla S, et al.
Publicado: (2021)

Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
por: Ishida, Kelly, et al.
Publicado: (2011)

In vitro antifungal potency of the moronecidin-like peptide against Candida albicans, Candida glabrata, and Candida tropicalis
por: Amirrajab, Nasrin, et al.
Publicado: (2023)

Clinical utility of antifungal susceptibility testing
por: McCarty, Todd P, et al.
Publicado: (2022)

Candida Species Biofilms’ Antifungal Resistance
por: Silva, Sónia, et al.
Publicado: (2017)

Candida auris: Epidemiology, biology, antifungal resistance, and virulence
por: Du, Han, et al.
Publicado: (2020)

Emergence of Nonalbicans Candida in Neonatal Septicemia and Antifungal Susceptibility: Experience from a Tertiary Care Center
por: Goel, Nidhi, et al.
Publicado: (2009)

Revisiting Species Distribution and Antifungal Susceptibility of Candida Bloodstream Isolates from Latin American Medical Centers
por: da Matta, Daniel Archimedes, et al.
Publicado: (2017)

Antifungal Susceptibility Pattern of Candida glabrata from a Referral Center and Reference Laboratory: 2012–2022
por: Chesdachai, Supavit, et al.
Publicado: (2023)

Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
por: Whaley, Sarah G., et al.
Publicado: (2017)

Blood Stream Infections by Candida glabrata and Candida krusei: A Single-Center Experience
por: Choi, Hee Kyoung, et al.
Publicado: (2009)

Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens
por: Rhimi, Wafa, et al.
Publicado: (2020)

Incidence and Antifungal Susceptibility of Candida Albicans Infections
por: UNGUREANU, A., et al.
Publicado: (2016)

Antifungal Resistance in Candida auris: Molecular Determinants
por: Frías-De-León, María Guadalupe, et al.
Publicado: (2020)

Identification and Elimination of Antifungal Tolerance in Candida auris
por: Rasouli Koohi, Samira, et al.
Publicado: (2023)

Evaluation of Candida colonization index, molecular identification, and antifungal susceptibility pattern of Candida species isolated from critically ill pediatric patients: A single-center study in Iran
por: Davari, Amirhossein, et al.
Publicado: (2022)

Microevolution of the pathogenic yeasts Candida albicans and Candida glabrata during antifungal therapy and host infection
por: Pais, Pedro, et al.
Publicado: (2019)

Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing
por: Spettel, Kathrin, et al.
Publicado: (2019)

Microsatellite Typing and Antifungal Susceptibility of Candida glabrata Strains Isolated From Patients With Candida Vaginitis
por: Kiasat, Neda, et al.
Publicado: (2019)

Molecular Epidemiology and Antifungal Susceptibility of Candida glabrata in China (August 2009 to July 2014): A Multi-Center Study
por: Hou, Xin, et al.
Publicado: (2017)

Antifungal Drug Concentration Impacts the Spectrum of Adaptive Mutations in Candida albicans
por: Todd, Robert T, et al.
Publicado: (2023)

Candida tropicalis is the most prevalent yeast species causing candidemia in Algeria: the urgent need for antifungal stewardship and infection control measures
por: Megri, Youcef, et al.
Publicado: (2020)

Stewardship-Guided T2Candida Testing Shortens Time to Antifungal Treatment and Reduces Antifungal Usage Among Medical Intensive Care Unit Patients With Septic Shock
por: O’Donnell, Matthew, et al.
Publicado: (2023)

194 Antimicrobial Stewardship Evaluation of Meropenem Use at a Large Academic Medical Center
por: Dubrovskaya, Yanina, et al.
Publicado: (2014)

1178. Risk factors for death among patients with Candida endocarditis: An observational study in US academic medical centers
por: Huggins, Jonathan, et al.
Publicado: (2020)

Operational impact of decreased turnaround times for Candida auris screening tests in a tertiary academic medical center
por: Arenas, Sebastian, et al.
Publicado: (2023)

Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
por: Mandras, Narcisa, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dkbjot42ictcqnbquoq91cfk87